Kobayashi Pharmaceutical Co., Ltd. (TYO:4967)
Japan flag Japan · Delayed Price · Currency is JPY
5,715.00
+24.00 (0.42%)
Aug 27, 2026, 9:52 AM JST

Kobayashi Pharmaceutical Cash Flow Statement

Millions JPY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
1,7173,74413,91427,55927,95027,636
Depreciation & Amortization
9,2018,7458,0226,0575,3584,835
Loss (Gain) From Sale of Assets
12,76212,65650118121378
Loss (Gain) From Sale of Investments
-3,392-3,041-635-43689-84
Other Operating Activities
-3,703-4,258-7,493-8,359-8,007-8,396
Change in Accounts Receivable
290-2,3954,780-3,7818,296-1,523
Change in Inventory
1,8551,392-1,144-3,175-1,977-462
Change in Accounts Payable
-1,8647,748-9,447361515-158
Change in Other Net Operating Assets
-5,0229993,19916-431193
Operating Cash Flow
11,84425,59011,24618,36031,91422,419
Operating Cash Flow Growth
-40.57%127.55%-38.75%-42.47%42.35%-6.53%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-17,800-13,253-26,056-12,756-14,747-3,663
Sale of Property, Plant & Equipment
2,4622,624225310
Cash Acquisitions
----11,176--
Divestitures
-----200
Sale (Purchase) of Intangibles
-956-758-573-813-1,482-522
Investment in Securities
14,30210,9348,0535,3952,16812,095
Other Investing Activities
-21299139-231-254-129
Investing Cash Flow
-2,013-154-18,415-19,576-14,3127,991

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Repaid
-----1-12
Total Debt Repaid
-----1-12
Net Debt Issued (Repaid)
-----1-12
Repurchase of Common Stock
----12,000-14,056-3,943
Common Dividends Paid
-7,729-7,653-7,505-7,223-6,509-6,251
Other Financing Activities
-271-268-263-240-193-171
Financing Cash Flow
-8,000-7,921-7,768-19,463-20,759-10,377

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
1,9321,2041,220890673797
Miscellaneous Cash Flow Adjustments
2----22-
Net Cash Flow
3,76518,719-13,717-19,789-2,50620,830

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-5,95612,337-14,8105,60417,16718,756
Free Cash Flow Growth
----67.36%-8.47%-7.11%
Free Cash Flow Margin
-3.56%7.44%-8.94%3.23%10.33%12.08%
Free Cash Flow Per Share
-80.12165.96-199.2273.89222.57240.08
Levered Free Cash Flow
-12,64918,250-13,0612,53511,18314,511
Unlevered Free Cash Flow
-12,63318,267-13,0432,55311,19414,522

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
242834221817
Cash Income Tax Paid
4,5944,1897,4718,3588,0038,464
Change in Working Capital
-4,7417,744-2,612-6,5796,403-1,950